These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC). Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F; Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop. Adrichem ME; Eftimov F; van Schaik IN J Peripher Nerv Syst; 2016 Sep; 21(3):121-7. PubMed ID: 27241239 [TBL] [Abstract][Full Text] [Related]
4. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies. Tracy JA; Dyck PJ Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial. van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS; Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial. Hughes RA Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683 [TBL] [Abstract][Full Text] [Related]
8. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy. Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749 [TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options. Eftimov F; van Schaik I Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276 [TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. RMC Trial Group Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303 [TBL] [Abstract][Full Text] [Related]
11. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy. Hughes RA Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659 [TBL] [Abstract][Full Text] [Related]
12. Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy. Kuitwaard K; Fokkink WR; Brusse E; Vrancken AFJE; Eftimov F; Notermans NC; van der Kooi AJ; Merkies ISJ; Jacobs BC; van Doorn PA J Peripher Nerv Syst; 2017 Dec; 22(4):425-432. PubMed ID: 29092099 [TBL] [Abstract][Full Text] [Related]
13. A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. Cornblath DR; Hartung HP; Katzberg HD; Merkies ISJ; van Doorn PA J Peripher Nerv Syst; 2018 Jun; 23(2):108-114. PubMed ID: 29603842 [TBL] [Abstract][Full Text] [Related]
14. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand. Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227 [TBL] [Abstract][Full Text] [Related]